Intensity Therapeutics, Inc.

Ownership Transactions Reported by 8 Insiders

Symbol
INTS on Nasdaq
Location
1 Enterprise Drive, Suite 430, Shelton, CT

There are no Buy or Sell transactions made by insiders since 10/25/2024

Intensity Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John M. Wesolowski Principal Accounting Officer $19.9K Jun 30, 2025
Joseph Talamo Chief Financial Officer $3.7K Jun 30, 2025
Daniel Donovan Director May 2, 2025
I. Dubin Thomas Director May 2, 2025
Emer Leahy Director May 2, 2025
James M. Ahlers Executive VP of CF Jun 29, 2023
Mark A. Goldberg Director May 2, 2025
Lewis H. Bender President and CEO, Director, 10%+ Owner May 2, 2025

Recent Insider Transactions by Companies or Individuals for Intensity Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.